Fig. 5From: High performance of targeted next generation sequencing on variance detection in clinical tumor specimens in comparison with current conventional methodsTargeted NGS to identify CNVs from clinical specimens. (a) The 14 breast cancer samples with NGS (HER2 amplification) positive were confirmed by FISH. (b) The results of 15 breast cancer samples with IHC (Her-2) 3+ were detected by targeted NGS. (c) The discordant result from sample 3D–B01 was further confirmed by FISHBack to article page